ACADIA Pharmaceuticals Inc. (ACAD)

ACADIA Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	128.51	-61.29	-215.98	-167.87	-281.58	-235.26
Depreciation & Amortization	12.31	5.55	2.03	3.34	2.93	2.77
Loss (Gain) From Sale of Assets	-	-	-	-	0.28	0
Asset Writedown & Restructuring Costs	-	-	-	-	44.28	-
Loss (Gain) From Sale of Investments	-8.27	-12.12	-6.28	0.08	2.47	-4.61
Stock-Based Compensation	74.62	66.42	68.2	63.62	84.42	82.27
Change in Accounts Receivable	-5.41	-36.07	2.17	-16.12	-12.47	-9.69
Change in Inventory	-60.19	-28.81	2.42	-4.21	-3.32	-1.74
Change in Accounts Payable	6.77	4.8	5.87	-1.62	1.27	4.06
Change in Other Net Operating Assets	54.39	78.22	27.54	-2.88	25.55	11.08
Operating Cash Flow	202.73	16.7	-114.04	-125.66	-136.17	-151.13
Capital Expenditures	-0.07	-0.05	-	-1.12	-7.59	-1.13
Sale (Purchase) of Intangibles	-	-40	-	-	-	-
Investment in Securities	-152.97	72.05	73.24	-69.98	200.1	-164.71
Investing Cash Flow	-153.04	32	73.24	-71.1	192.51	-165.84
Issuance of Common Stock	10.31	25.13	8.2	18.16	81	371.85
Financing Cash Flow	10.31	25.13	8.2	18.16	81	371.85
Foreign Exchange Rate Adjustments	-0.05	-0.02	0.01	0.01	-0.01	0
Net Cash Flow	59.96	73.81	-32.59	-178.59	137.33	54.88
Free Cash Flow	202.66	16.65	-114.04	-126.78	-143.75	-152.26
Free Cash Flow Margin	21.81%	2.29%	-22.05%	-26.19%	-32.54%	-44.90%
Free Cash Flow Per Share	1.22	0.10	-0.71	-0.79	-0.91	-1.03
Cash Income Tax Paid	5.85	5.85	2.19	1.04	1.11	1.6
Levered Free Cash Flow	221.72	28.44	-34.96	-65.26	-59.7	-68.6
Unlevered Free Cash Flow	221.72	28.44	-34.96	-65.26	-59.7	-68.6
Change in Net Working Capital	-64.72	-42.38	-34.56	24.58	-6.65	-1.59

Source: S&P Capital IQ. Standard template. Financial Sources.